The innovative Hero Gauntlet, designed by Open Bionics, is a groundbreaking device tailored for individuals with partial hand amputations or congenital limb differences, offering them renewed independence and functionality.

Michael Altheim’s life changed dramatically a decade ago when he lost all four fingers on his right hand in a work-related accident. The limitations of previous prosthetic solutions, which were heavy, minimally functional, and not waterproof, added to his challenges. The Hero Gauntlet aims to address these issues, providing a more effective and user-friendly alternative.

Analyzing the plasma proteins of patients with sepsis can provide critical insights into the severity and prognosis of the condition, researchers report. Their findings demonstrate how affordable, high-throughput proteomics using mass spectrometry (MS) can effectively map the plasma proteome, revealing differences in patient responses.

The study, published in Science Translational Medicine, identified three distinct clusters of sepsis patients based on their plasma proteomes. These clusters were indicative of the patients’ response states, disease severity, and outcomes. The researchers found that a patient’s assignment to a particular cluster could change over time, suggesting potential applications for therapeutic intervention and disease progression monitoring.

A new method for predicting dementia, developed by researchers at Queen Mary University of London, has demonstrated over 80% accuracy and can identify the onset of the condition up to nine years before a formal diagnosis. This innovative approach surpasses traditional methods such as memory tests and measurements of brain shrinkage, which are currently used to diagnose dementia.

The significance of this advancement is underscored by the global impact of dementia, which affects over 55 million people worldwide. Early and accurate diagnosis has been a longstanding challenge in the medical community.